Targeted Stem Cell Therapy for Chronic Kidney Disease (CKD)

Benefits of Stem Cell Therapy for Kidney Patients

Patients who undergo our targeted Mesenchymal Stem Cell (MSC) therapy for chronic kidney disease (CKD) often report significant clinical improvements within 3 to 6 months. These benefits are both measurable and meaningful, offering a renewed sense of hope and vitality, especially for those in stages 3 to 5 of kidney disease.

1. Improved Glomerular Filtration Rate (GFR) & Reduced Creatinine Levels

Stem cell therapy has been shown to enhance kidney filtration capacity by stimulating the repair of damaged nephrons. This leads to:

• A notable increase in GFR, a key indicator of kidney function.

• A drop in serum creatinine levels, reflecting reduced kidney strain and improved waste clearance.

2. Reduced Proteinuria and Inflammation Markers

Chronic inflammation and high protein levels in urine (proteinuria) are both hallmark signs of CKD. Stem cells:

• Suppress pro-inflammatory cytokines like TNF-α and IL-6.

• Promote anti-inflammatory healing, reducing immune-mediated damage to kidney tissues.

• Result in reduced albumin loss in urine, which helps slow disease progression.

3. Stabilised Blood Pressure & Metabolic Function

CKD often leads to uncontrolled hypertension and metabolic imbalance. After stem cell infusion:

• Many patients report better blood pressure control, even with reduced antihypertensive medication.

• Improved glucose handling and lipid regulation is observed in some cases, especially among diabetic nephropathy patients.

4. Delayed or Avoided Dialysis

For patients in advanced stages of CKD, MSC therapy may offer an alternative to dialysis by:

• Slowing or even reversing certain aspects of kidney decline.

• Delaying the need for dialysis initiation.

• In some early-stage dialysis patients, improving enough to reduce dialysis frequency.

5. Reduced Fatigue, Swelling, and Uremic Symptoms

Quality of life is a major concern for CKD patients. Post-treatment:

• Patients often feel less fatigued, with improved energy levels.

• Reduced fluid retention, leading to less swelling in legs and ankles.

• Relief from symptoms like nausea, cramps, and metallic taste in the mouth often associated with uremia.

Why These Results Matter
Stem cell therapy targets the root cause of kidney deterioration by regenerating microvascular structures, reducing scarring (fibrosis), and rebalancing immune system responses. The outcome is not just symptom management but true regenerative potential.